In the BioHarmony Drug Report Database

"Preview" Icon

Ceftolozane

Zerbaxa (ceftolozane) is a small molecule pharmaceutical. Ceftolozane was first approved as Zerbaxa on 2014-12-19. It is used to treat bacterial infections, bacteroides infections, escherichia coli infections, intraabdominal infections, and klebsiella infections amongst others in the USA. It has been approved in Europe to treat bacterial infections. Zerbaxa’s patents are valid until 2035-08-14 (FDA).

 

Trade Name

 

Zerbaxa
 

Common Name

 

ceftolozane
 

ChEMBL ID

 

CHEMBL2103872
 

Indication

 

bacterial infections, bacteroides infections, escherichia coli infections, intraabdominal infections, klebsiella infections, proteus infections, pseudomonas infections, streptococcal infections, urinary tract infections
 

Drug Class

 

Cephalosporins

Image (chem structure or protein)

Ceftolozane structure rendering